🟢 Pyxis Oncology is trading 6.75% up in pre-market amid possible H.C. Wainwright event anticipation

Pyxis Oncology is trading 6.75% up at $3.43, with no clearly identified overnight company announcement explaining the September 14, 2026 pre-market move.

• Scheduled for the H.C. Wainwright 28th Annual Global Investment Conference at 9:30 a.m. EDT; the earlier-announced event may be attracting speculative interest.
• Recent MICVO data showed a 36% confirmed response rate and 94% disease-control rate.
• Broader market is weaker pre-market; move is low-confidence, not risk-on, and may reflect event anticipation or biotech volatility.